跳至主要内容
临床试验/NCT07530497
NCT07530497招募中不适用

Real World Evidence of SI-BONE's iFuse TORQ TNT Advancing Treatment of Pelvic Ring Fractures

SI-BONE, Inc.2 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2026年8月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
SI-BONE, Inc.
入组人数
120
试验地点
2
主要终点
Composite Measure

研究概览

简要总结

The purpose of this study is to evaluate outcomes in patients treated with iFuse TORQ TNT for pelvic fragility fractures.

详细描述

REBAR is a prospective, multicenter, single arm, post-market observational study conducted in a real-world setting on the usage of iFuse TORQ TNT.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
60 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ≥ 60 years of age at screening
  • Pelvic pain correlating with fracture location that began EITHER within 6 weeks of a known low-energy traumatic event, OR pelvic insufficiency fracture with pain that is limiting mobility
  • Diagnostic imaging (X-ray and CT) showing fracture of the pelvis that correlates with pain location
  • Patient is scheduled for pelvic fixation using at least one iFuse TORQ TNT
  • Patient and/or patient's legally authorized representative (LAR) understands and is willing and able to provide written informed consent
  • Patient agrees to comply with study schedule of assessments
  • Patient and/or patient's proxy can complete study-related surveys
  • Patient was able to ambulate prior to index fracture

排除标准

  • Any known anatomic issues that could prevent placement of iFuse TORQ TNT
  • Implants already in the pelvis (e.g. lumbopelvic fixation) that could interfere with placement of the study device(s)
  • Patient requires lumbosacral pelvic fixation as part of index procedure
  • Prominent neurologic or uncontrolled psychiatric condition that would interfere with study participation or regaining of physical function related to pelvic fracture and is unable to provide a health care proxy to complete study assessments.
  • Estimated lifespan < 12 months
  • Presence of tumor, lytic lesion, infection, or soft tissues that precludes safe internal fixation
  • Not candidate for surgery due to underlying medical illness
  • Social situation that makes 12-month follow-up unlikely
  • History of recent (within 1 year) non-index pelvic fracture with non-union
  • Other clinically active fragility fracture of spine, hip or arms/legs that could impair recovery from sacral fracture
  • Known allergy to titanium or titanium alloys
  • Known or suspected active drug or alcohol abuse, including opioids
  • Patient is a prisoner or ward of the state
  • Patient is already participating in an investigational clinical trial that may interfere with implant placement or study follow-up

研究组 & 干预措施

FFP using iFuse TORQ TNT.

Patients with fragility fractures of the pelvis (FFP) treated with surgical fixation using iFuse TORQ TNT.

干预措施: iFuse TORQ TNT Implant System (Device)

结局指标

主要结局

Composite Measure

时间窗: 6-months

The participant is considered a success if all of the following apply: * No breakage of study device on any radiographic study * No detectable migration or backout of study device compared to immediate postop or end-of-procedure view * No revision surgery related to the study device

次要结局

  • Safety endpoint(12 months)
  • Safety endpoint: Proportion of Participants with ≥1 Serious Adverse Event (SAE)(12 months)

研究者

发起方
SI-BONE, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验